Cargando…
Recent Advances in HIV-1 Gag Inhibitor Design and Development
Acquired Immune Deficiency Syndrome (AIDS) treatment with combination antiretroviral therapy (cART) has improved the life quality of many patients since its implementation. However, resistance mutations and the accumulation of severe side effects associated with cART remain enormous challenges that...
Autores principales: | Dick, Alexej, Cocklin, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181048/ https://www.ncbi.nlm.nih.gov/pubmed/32272714 http://dx.doi.org/10.3390/molecules25071687 |
Ejemplares similares
-
Bioisosteric Replacement as a Tool in Anti-HIV Drug Design
por: Dick, Alexej, et al.
Publicado: (2020) -
Subtype Differences in the Interaction of HIV-1 Matrix with Calmodulin: Implications for Biological Functions
por: Dick, Alexej, et al.
Publicado: (2021) -
Clade-Specific Alterations within the HIV-1 Capsid Protein with Implications for Nuclear Translocation
por: Dick, Alexej, et al.
Publicado: (2022) -
Reviewing HIV-1 Gag Mutations in Protease Inhibitors Resistance: Insights for Possible Novel Gag Inhibitor Designs
por: Su, Chinh Tran-To, et al.
Publicado: (2019) -
Field-Based Affinity Optimization of a Novel Azabicyclohexane Scaffold HIV-1 Entry Inhibitor
por: Meuser, Megan E., et al.
Publicado: (2019)